Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000494:pharmacology; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000187:drug effects; D005260:Female; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000503:physiopathology; D007951:Leukemia, Myeloid / Q000097:blood; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000097:blood*; D010973:Platelet Adhesiveness; D011087:Polycythemia Vera / Q000097:blood; D055728:Primary Myelofibrosis / Q000097:blood; D013925:Thromboplastin / Q000502:physiology*
D000970:Antineoplastic Agents; D013925:Thromboplastin